Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DARE/Shareholders’ equity

Dare Bioscience, Inc. (DARE) Shareholders’ equity 2016–2025

Dare Bioscience, Inc. (DARE) shareholders’ equity at each fiscal year-end, per SEC filings.

$2.8MFY2025 · since FY2016: -$710,621 → $2.8M
162122232425
Fiscal yearValueYoY
FY2025$2.8M+147.3%
FY2024-$6.0M-19.1%
FY2023-$5.0M-145.4%
FY2022$11.1M-71.3%
FY2021$38.8M—
FY2016-$710,621—

Source: SEC XBRL filings · For reference only · Not investment advice

More DARE financial trends

DARE RevenueDARE Net incomeDARE Net marginDARE Gross profitDARE Gross marginDARE Operating incomeDARE Operating marginDARE Operating cash flowDARE Free cash flowDARE Capital expendituresDARE Return on equityDARE Stock buybacksDARE Dividends paidDARE Total assetsDARE Total liabilitiesDARE overview →